Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ACT-385781A (Actelion Epoprostenol)1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
2Current marketed FLOLAN (epoprostenol sodium)1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
3EPOPROSTENOL1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
4Epoprostenol for injection1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
5EPOPROSTENOL SODICO1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
6EPOPROSTENOL SODIUM1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
7Epoprostenol-Actelion1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
8Epoprostenolo per iniezione----1件: 86
9New thermo stable formulation of epoprostenol sodium1件: Epoprostenol1件: D00106 (Name: Epoprostenol)1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86